C. Verkindre
发表
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
C. Vogelmeier,
R. Zeldin,
J. Galdiz,
2010,
Pulmonary pharmacology & therapeutics.
T. Perez,
M. Brun,
A. Tonnel,
2008,
International journal of chronic obstructive pulmonary disease.
A. Tonnel,
F. Radenne,
C. Verkindre,
2004,
Revue des maladies respiratoires.
F. Bart,
J. Guerin,
B. Aguilaniu,
2006,
Respiration.
C. Marquette,
P. Ramon,
A. Brichet,
1999,
The European respiratory journal.
J. Pépin,
S. Bailly,
R. Tamisier,
2019,
Sleep medicine.
M. Humbert,
A. Didier,
P. Chanez,
2010,
Respiratory medicine.
Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
Y Fukuchi,
Y. Fukuchi,
N. Prasad,
2010,
Respiratory medicine.
C. Marquette,
P. Ramon,
A. Brichet,
1999,
The European respiratory journal.
H. Magnussen,
D. Jadayel,
R. Woessner,
2010,
Respiratory medicine.
B. Kramer,
M. Higgins,
R. Owen,
2009,
ATS 2009.